Open an account

Ingevity

NGVT · NYSE

$70.60+$0.29 (+0.41%)TodayMarket closed ·
Prev close $70.31

About NGVT

Ingevity Corp. engages in the manufacture of specialty chemicals and carbon materials. The company is headquartered in North Charleston, South Carolina and currently employs 1,500 full-time employees. The company went IPO on 2016-05-02. The firm operates in three reporting segments: Performance Materials, Advanced Polymer Technologies, and Performance Chemicals. The Performance Materials segment manufactures products in the form of powder, granular, extruded pellets, extruded honeycombs, and activated carbon sheets. Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. Performance chemicals include pavement technologies and road markings. The Company’s products are used in a variety of demanding applications, including automotive gasoline vapor emissions control systems, food, water and chemical filtration, asphalt paving, agrochemical dispersants, bioplastics, coatings, elastomers, and paint for road markings.

Employees
1,500
Headquarters
North Charleston, South Carolina
Listed
May 2, 2016
Sector
Materials
Industry
Chemicals
Website
ingevity.com

NGVT key statistics

Market cap
2.42B
Price-earnings ratio
62.78
Dividend yield
—
Average volume
255.96K
Volume
264.52K
Open price
$70.24
High today
$72.23
Low today
$70.19
52 Week high
$79.29
52 Week low
$45.85

Ingevity (NGVT) at a glance

Ingevity (NGVT) last traded at $70.60, with a market cap of 2.42B and a price-to-earnings ratio of 62.78.

Today the stock has traded between $70.19 and $72.23. The current price is 0.6% above the day's low and 2.3% below its high.

Volume so far is 264.52K shares, in line with the average of 255.96K shares a day.

Over the past year Ingevity has ranged from $45.85 to $79.29, and now sits 74% of the way up that range.

Ingevity met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $1.74 per share against an estimate of $1.35.

The average analyst price target is $92.48, 31.0% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

50%of 2 analyst ratings say Buy
  • Buy50.0%
  • Hold50.0%
  • Sell0.0%
Price target · 5 analystsAvg $92.48
Low
$85.85
Now
$70.60
High
$99.75

NGVT earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 50.3% on average.

  1. Q3 FY24: reported $1.10 per share against an estimate of $0.918
  2. Q4 FY24: reported $0.95 per share against an estimate of $0.3137
  3. Q1 FY25: reported $0.99 per share against an estimate of $0.7523
  4. Q2 FY25: reported $1.39 per share against an estimate of $1.19
  5. Q3 FY25: reported $1.52 per share against an estimate of $1.42
  6. Q4 FY25: reported $0.63 per share against an estimate of $0.7013
  7. Q1 FY26: reported $1.15 per share against an estimate of $0.7931
  8. Q2 FY26: reported $1.74 per share against an estimate of $1.35

NGVT news

  • Press releaseBusiness Wire

    Ingevity announces dates for third quarter 2026 earnings release and webcast

  • Press releaseBusiness Wire

    Ingevity CEO Dave Li to speak at 2026 Water Tower Research Insights Conference

  • Press releaseBusiness Wire

    Ingevity CEO Dave Li and CFO Phil Platt to speak at 2026 Jefferies Global Industrials Conference

  • Press releaseBusiness Wire

    Ingevity included in TIME America’s Best Companies 2026 list

  • Press releaseBusiness Wire

    Ingevity Releases 2025 Sustainability Report, Highlights Performance and Impact

  • Press releaseBusiness Wire

    Ingevity reports second quarter 2026 financial results

  • Press releaseBusiness Wire

    Ingevity’s Evotherm® P35 receives BASt approval in Germany

  • Press releaseBusiness Wire

    Ingevity announces dates for second quarter 2026 earnings release and webcast

Similar companies

Companies in the same industry as Ingevity

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.